Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04713891
Title A Study of KF-0210 in Advanced Solid Tumors Patients
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Keythera Pharmaceuticals (Australia) Pty Ltd
Indications

colorectal cancer

stomach cancer

Advanced Solid Tumor

lung cancer

urinary bladder cancer

esophagus squamous cell carcinoma

Therapies

KF-0210

Atezolizumab + KF-0210

Age Groups: adult | senior
Covered Countries


No variant requirements are available.